References
- De Gara C J, Gledhill T, Hunt R H. Nocturnal gastric acid secretion: its importance in the pathophysiology and rational therapy of duodenal ulcer. Scand J Gastroenterol 1986; 21(suppl 121)17–24
- Ireland A, Colin Jones D G, Gear P. Comparison of ranitidine 150 mg twice a day with ranitidine 300 mg as a single evening dose in the treatment of duodenal ulcers. Lancet 1984; 2: 274–276
- Jones D B, Howden C W, Burget D W, Kerr G D, Hunt R H. Acid suppression in duodenal ulcer: a metanalysis to define optimal dosing with antisecretory drugs. Gut 1987; 28: 1120–1127
- Merki H S, Witzel L, Harre K, Scheurle E, Neumann J, Röhmel J. Single dose treatment with H2-receptor antagonists: is bedtime administration too late?. Gut 1987; 28: 451–454
- Gledhill T, Howard O M, Buck M, Paul A, Hunt R H. Single nocturnal dose of an H2-receptor antagonist for treatment of duodenal ulcer. Gut 1983; 24: 904–908
- Merki H S, Halter F, Wilder-Smith C H, et al. Effect of food on H2-receptor blockade in normal subjects and duodenal ulcer patients. Gut 1990; 31: 148–150
- Johnston D A, Wormsley K G. The effect of food on ranitidine-induced inhibition of nocturnal gastric secretion. Aliment Pharmacol Ther 1988; 2: 507–511
- Burget D W, Chiverton S G, Hunt R H. Is there an optimal degree of acid suppression for healing of duodenal ulcers?. Gastroenterology 1990; 99: 345–351
- Bianchi Porro G, Parente F, Sangaletti O. Inhibition of nocturnal acidity is important but not essential for duodenal ulcer healing. Gut 1990; 31: 397–400
- Wilder-Smith C H, Halter F, Merki H S. The effect of different dosing regimens of the long-acting H2-receptor antagonist sufotidine on intragastric acidity. Eur J Gastroenterol Hepatol 1990; 2: 373–377
- Chiverton S G, Burget D W, Hunt R H. Do H2-receptor antagonists have to be given at night? A study of the antisecretory profile of SKF 94482, a new H2-receptor antagonist which has a profound effect on daytime acidity. Gut 1989; 30: 594–599
- Merki H S, Wilder-Smith C H, Walt R P, Hunt R H, Renner E L, Halter F. Differential circadian effects and development of tolerance to an H2-receptor antagonist. Gastroenterology 1990; 98: A88–A96
- Wilder-Smith C H, Ernst T, Gennoni M, Zeyen B, Halter F, Merki H S. Tolerance to oral H2-receptor antagonists. Dig Dis Sci 1990; 35: 976–983
- Wilder-Smith C H, Halter F, Ernst T, et al. Loss of acid suppression during dosing with H2-receptor antagonists. Aliment Pharmacol Ther 1990; 4(suppl 1)15–27
- Smith J TL, Gavey C J, Nwokolo C U, Pounder R E. Tolerance during eight days of high dose H2-blockade: placebo controlled studies of 24 hour acidity and gastrin. Gut 1989; 30: A1487–A1496